Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1990 Sep;64(3):174–176. doi: 10.1136/hrt.64.3.174

Late potentials as predictors of risk after thrombolytic treatment?

G Breithardt 1, M Borggrefe 1, U Karbenn 1
PMCID: PMC1024366  PMID: 2206709

Full text

PDF
174

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bassand J. P., Machecourt J., Cassagnes J., Anguenot T., Lusson R., Borel E., Peycelon P., Wolf E., Ducellier D. Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function. J Am Coll Cardiol. 1989 Apr;13(5):988–997. doi: 10.1016/0735-1097(89)90249-0. [DOI] [PubMed] [Google Scholar]
  2. Blankenhorn D. H., Kramsch D. M. Reversal of atherosis and sclerosis. The two components of atherosclerosis. Circulation. 1989 Jan;79(1):1–7. doi: 10.1161/01.cir.79.1.1. [DOI] [PubMed] [Google Scholar]
  3. Breithardt G., Becker R., Seipel L., Abendroth R. R., Ostermeyer J. Non-invasive detection of late potentials in man--a new marker for ventricular tachycardia. Eur Heart J. 1981 Feb;2(1):1–11. doi: 10.1093/oxfordjournals.eurheartj.a061158. [DOI] [PubMed] [Google Scholar]
  4. Breithardt G., Borggrefe M., Karbenn U., Abendroth R. R., Yeh H. L., Seipel L. Prevalence of late potentials in patients with and without ventricular tachycardia: correlation with angiographic findings. Am J Cardiol. 1982 Jun;49(8):1932–1937. doi: 10.1016/0002-9149(82)90212-0. [DOI] [PubMed] [Google Scholar]
  5. Breithardt G., Borggrefe M., Martinez-Rubio A., Budde T. Pathophysiological mechanisms of ventricular tachyarrhythmias. Eur Heart J. 1989 Sep;10 (Suppl E):9–18. doi: 10.1093/eurheartj/10.suppl_e.9. [DOI] [PubMed] [Google Scholar]
  6. Breithardt G., Borggrefe M. Pathophysiological mechanisms and clinical significance of ventricular late potentials. Eur Heart J. 1986 May;7(5):364–385. doi: 10.1093/oxfordjournals.eurheartj.a062078. [DOI] [PubMed] [Google Scholar]
  7. Breithardt G., Borggrefe M., Quantius B., Karbenn U., Seipel L. Ventricular vulnerability assessed by programmed ventricular stimulation in patients with and without late potentials. Circulation. 1983 Aug;68(2):275–281. doi: 10.1161/01.cir.68.2.275. [DOI] [PubMed] [Google Scholar]
  8. Breithardt G., Borggrefe M. Recent advances in the identification of patients at risk of ventricular tachyarrhythmias: role of ventricular late potentials. Circulation. 1987 Jun;75(6):1091–1096. doi: 10.1161/01.cir.75.6.1091. [DOI] [PubMed] [Google Scholar]
  9. Dalen J. E., Gore J. M., Braunwald E., Borer J., Goldberg R. J., Passamani E. R., Forman S., Knatterud G. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. Am J Cardiol. 1988 Aug 1;62(4):179–185. doi: 10.1016/0002-9149(88)90208-1. [DOI] [PubMed] [Google Scholar]
  10. Darius H., Yanagisawa A., Brezinski M. E., Hock C. E., Lefer A. M. Beneficial effects of tissue-type plasminogen activator in acute myocardial ischemia in cats. J Am Coll Cardiol. 1986 Jul;8(1):125–131. doi: 10.1016/s0735-1097(86)80102-4. [DOI] [PubMed] [Google Scholar]
  11. Eldar M., Leor J., Hod H., Rotstein Z., Truman S., Kaplinsky E., Abboud S. Effect of thrombolysis on the evolution of late potentials within 10 days of infarction. Br Heart J. 1990 May;63(5):273–276. doi: 10.1136/hrt.63.5.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gang E. S., Lew A. S., Hong M., Wang F. Z., Siebert C. A., Peter T. Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1989 Sep 14;321(11):712–716. doi: 10.1056/NEJM198909143211104. [DOI] [PubMed] [Google Scholar]
  13. Gardner P. I., Ursell P. C., Fenoglio J. J., Jr, Wit A. L. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation. 1985 Sep;72(3):596–611. doi: 10.1161/01.cir.72.3.596. [DOI] [PubMed] [Google Scholar]
  14. Guerci A. D., Gerstenblith G., Brinker J. A., Chandra N. C., Gottlieb S. O., Bahr R. D., Weiss J. L., Shapiro E. P., Flaherty J. T., Bush D. E. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med. 1987 Dec 24;317(26):1613–1618. doi: 10.1056/NEJM198712243172601. [DOI] [PubMed] [Google Scholar]
  15. Jaffe A. S. New mechanisms of action for tissue-type plasminogen activator? J Am Coll Cardiol. 1986 Jul;8(1):132–133. doi: 10.1016/s0735-1097(86)80103-6. [DOI] [PubMed] [Google Scholar]
  16. Josephson M. E., Horowitz L. N., Farshidi A., Spielman S. R., Michelson E. L., Greenspan A. M. Sustained ventricular tachycardia: evidence for protected localized reentry. Am J Cardiol. 1978 Sep;42(3):416–424. doi: 10.1016/0002-9149(78)90936-0. [DOI] [PubMed] [Google Scholar]
  17. Kennedy J. W., Martin G. V., Davis K. B., Maynard C., Stadius M., Sheehan F. H., Ritchie J. L. The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. Circulation. 1988 Feb;77(2):345–352. doi: 10.1161/01.cir.77.2.345. [DOI] [PubMed] [Google Scholar]
  18. Kersschot I. E., Brugada P., Ramentol M., Zehender M., Waldecker B., Stevenson W. G., Geibel A., De Zwaan C., Wellens H. J. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study. J Am Coll Cardiol. 1986 Jun;7(6):1234–1242. doi: 10.1016/s0735-1097(86)80141-3. [DOI] [PubMed] [Google Scholar]
  19. Kienzle M. G., Miller J., Falcone R. A., Harken A., Josephson M. E. Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia. Circulation. 1984 Dec;70(6):957–965. doi: 10.1161/01.cir.70.6.957. [DOI] [PubMed] [Google Scholar]
  20. Klein H., Karp R. B., Kouchoukos N. T., Zorn G. L., Jr, James T. N., Waldo A. L. Intraoperative electrophysiologic mapping of the ventricles during sinus rhythm in patients with a previous myocardial infarction. Identification of the electrophysiologic substrate of ventricular arrhythmias. Circulation. 1982 Oct;66(4):847–853. doi: 10.1161/01.cir.66.4.847. [DOI] [PubMed] [Google Scholar]
  21. Kloner R. A., Alker K. J. The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion. Circulation. 1984 Sep;70(3):513–521. doi: 10.1161/01.cir.70.3.513. [DOI] [PubMed] [Google Scholar]
  22. Lefer A. M., Mentley R., Sun J. Z. Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium. Circ Res. 1988 Sep;63(3):621–627. doi: 10.1161/01.res.63.3.621. [DOI] [PubMed] [Google Scholar]
  23. Marino P., Zanolla L., Zardini P. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. J Am Coll Cardiol. 1989 Nov 1;14(5):1149–1158. doi: 10.1016/0735-1097(89)90409-9. [DOI] [PubMed] [Google Scholar]
  24. Ostermeyer J., Breithardt G., Kolvenbach R., Körfer R., Seipel L., Schulte H. D., Bircks W. Intraoperative electrophysiologic mapping during cardiac surgery. Thorac Cardiovasc Surg. 1979 Aug;27(4):260–270. doi: 10.1055/s-0028-1096257. [DOI] [PubMed] [Google Scholar]
  25. Richards D. A., Blake G. J., Spear J. F., Moore E. N. Electrophysiologic substrate for ventricular tachycardia: correlation of properties in vivo and in vitro. Circulation. 1984 Feb;69(2):369–381. doi: 10.1161/01.cir.69.2.369. [DOI] [PubMed] [Google Scholar]
  26. Ritchie J. L., Cerqueira M., Maynard C., Davis K., Kennedy J. W. Ventricular function and infarct size: the Western Washington Intravenous Streptokinase in Myocardial Infarction Trial. J Am Coll Cardiol. 1988 Apr;11(4):689–697. doi: 10.1016/0735-1097(88)90197-0. [DOI] [PubMed] [Google Scholar]
  27. Simoons M. L., Vos J., Tijssen J. G., Vermeer F., Verheugt F. W., Krauss X. H., Cats V. M. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. J Am Coll Cardiol. 1989 Dec;14(7):1609–1615. doi: 10.1016/0735-1097(89)90003-x. [DOI] [PubMed] [Google Scholar]
  28. Simson M. B. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation. 1981 Aug;64(2):235–242. doi: 10.1161/01.cir.64.2.235. [DOI] [PubMed] [Google Scholar]
  29. Treese N., Pop T., Erbel R., Meinertz T., Helmling P., von Olshausen K., Meyer J. Outcome of primary coronary recanalization and arrhythmia profile in survivors of acute myocardial infarction. Int J Cardiol. 1987 Apr;15(1):19–31. doi: 10.1016/0167-5273(87)90289-0. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES